Nyxoah SA (NYXH)
10.10
-0.33
(-3.16%)
USD |
NASDAQ |
May 17, 16:00
10.10
0.00 (0.00%)
After-Hours: 20:00
Nyxoah Profit Margin (Quarterly): -975.1% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -975.1% |
| December 31, 2023 | -597.2% |
| September 30, 2023 | -779.9% |
| June 30, 2023 | -1.16K% |
| March 31, 2023 | -2.70K% |
| December 31, 2022 | -1.02K% |
| September 30, 2022 | -3.43K% |
| Date | Value |
|---|---|
| June 30, 2022 | -533.1% |
| March 31, 2022 | -1.02K% |
| December 31, 2021 | -2.12K% |
| September 30, 2021 | -4.32K% |
| June 30, 2021 | -4.08K% |
| March 31, 2021 | -3.06K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-4.32K%
Minimum
Sep 2021
-533.1%
Maximum
Jun 2022
-1.98K%
Average
-1.16K%
Median
Jun 2023
Profit Margin (Quarterly) Benchmarks
| Galapagos NV | -- |
| UCB SA | -- |
| Mithra Pharmaceuticals SA | -- |
| Celyad Oncology SA | -- |
| MDxHealth SA | -42.91% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -40.48% |
| Return on Assets | -32.52% |
| Return on Invested Capital | -37.36% |
| Gross Profit Margin (Quarterly) | 62.74% |
| Operating Margin (Quarterly) | -1.00K% |
| Return on Net Operating Assets | -58.83% |